Colin Phipps Diong

622 total citations
23 papers, 278 citations indexed

About

Colin Phipps Diong is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Colin Phipps Diong has authored 23 papers receiving a total of 278 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 8 papers in Oncology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Colin Phipps Diong's work include Hematopoietic Stem Cell Transplantation (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Viral-associated cancers and disorders (6 papers). Colin Phipps Diong is often cited by papers focused on Hematopoietic Stem Cell Transplantation (8 papers), Lymphoma Diagnosis and Treatment (7 papers) and Viral-associated cancers and disorders (6 papers). Colin Phipps Diong collaborates with scholars based in Singapore, South Korea and United States. Colin Phipps Diong's co-authors include Yeh Ching Linn, Kok Loon Wong, Siew Cheng Wong, Wei Hseun Yeap, Noriko Shimasaki, Antonio Bertoletti, William Ying Khee Hwang, Sathish Gopalakrishnan, Aloysius Ho and Li Mei Poon and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Scientific Reports.

In The Last Decade

Colin Phipps Diong

19 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Colin Phipps Diong Singapore 6 128 94 54 50 46 23 278
Nashla Barroso United States 4 109 0.9× 28 0.3× 58 1.1× 61 1.2× 48 1.0× 7 324
Krishan Thirunavukkarasu Australia 7 121 0.9× 78 0.8× 22 0.4× 42 0.8× 142 3.1× 9 430
Dipenkumar Modi United States 10 65 0.5× 129 1.4× 31 0.6× 64 1.3× 132 2.9× 61 272
Malini Bhole United Kingdom 6 125 1.0× 38 0.4× 59 1.1× 31 0.6× 79 1.7× 11 294
Yvonne Sundström Sweden 10 260 2.0× 74 0.8× 35 0.6× 33 0.7× 30 0.7× 13 397
Elizabeth Brém United States 10 59 0.5× 112 1.2× 86 1.6× 93 1.9× 36 0.8× 35 270
Lena Marinova Bulgaria 8 155 1.2× 76 0.8× 33 0.6× 16 0.3× 31 0.7× 21 361
Shin‐ichi Fuchida Japan 11 55 0.4× 107 1.1× 87 1.6× 37 0.7× 169 3.7× 38 294
Luis Aversa Argentina 10 38 0.3× 73 0.8× 27 0.5× 71 1.4× 126 2.7× 19 336
Shin Young Hyun South Korea 10 65 0.5× 86 0.9× 41 0.8× 44 0.9× 125 2.7× 29 269

Countries citing papers authored by Colin Phipps Diong

Since Specialization
Citations

This map shows the geographic impact of Colin Phipps Diong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Phipps Diong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Phipps Diong more than expected).

Fields of papers citing papers by Colin Phipps Diong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Phipps Diong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Phipps Diong. The network helps show where Colin Phipps Diong may publish in the future.

Co-authorship network of co-authors of Colin Phipps Diong

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Phipps Diong. A scholar is included among the top collaborators of Colin Phipps Diong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Phipps Diong. Colin Phipps Diong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yunxin, Melissa Ooi, Sanjay De Mel, et al.. (2023). AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management. Annals of the Academy of Medicine Singapore. 52(11). 601–624. 2 indexed citations
2.
Dreyling, Martin, Armando Santoro, Sirpa Leppä, et al.. (2023). Six-year safety and efficacy results from the CHRONOS-1 study of the PI3K inhibitor copanlisib in patients with relapsed or refractory follicular lymphoma.. Journal of Clinical Oncology. 41(16_suppl). 7555–7555. 3 indexed citations
3.
Dreyling, Martin, Armando Santoro, Sirpa Leppä, et al.. (2019). EFFICACY AND SAFETY IN HIGH‐RISK RELAPSED OR REFRACTORY INDOLENT FOLLICULAR LYMPHOMA PATIENTS TREATED WITH COPANLISIB. Hematological Oncology. 37(S2). 387–389. 6 indexed citations
4.
Leppä, Sirpa, Armando Santoro, Judit Demeter, et al.. (2019). Long-term follow-up of patients (pts) with relapsed or refractory (r/r) follicular lymphoma (FL) treated with copanlisib.. Journal of Clinical Oncology. 37(15_suppl). 7553–7553.
5.
Chan, Esther Hian Li, Liang Piu Koh, Joanne Lee, et al.. (2019). Real world experience of R‐CHOP with or without consolidative radiotherapy vs DA‐EPOCH‐R in the first‐line treatment of primary mediastinal B‐cell lymphoma. Cancer Medicine. 8(10). 4626–4632. 26 indexed citations
6.
7.
Lim, Francesca, Colin Phipps Diong, Yeow Tee Goh, et al.. (2018). Donor‐type fresh frozen plasma is effective in preventing hemolytic reaction in major ABO incompatible allogeneic stem cell transplant. Transfusion. 59(1). 335–339. 2 indexed citations
8.
Dreyling, Martin, Armando Santoro, Sirpa Leppä, et al.. (2017). Copanlisib in patients with relapsed or refractory follicular lymphoma.. Journal of Clinical Oncology. 35(15_suppl). 7535–7535. 4 indexed citations
9.
Zhou, Wei, Rehena Sultana, Colin Phipps Diong, et al.. (2017). Long‐term renal outcome after allogeneic hemopoietic stem cell transplant: A comprehensive analysis of risk factors in an Asian patient population. Clinical Transplantation. 31(4). 2 indexed citations
10.
Yeap, Wei Hseun, Kok Loon Wong, Noriko Shimasaki, et al.. (2016). CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Scientific Reports. 6(1). 34310–34310. 171 indexed citations
11.
Diong, Colin Phipps, S. Gopalakrishnan, Aloysius Ho, et al.. (2016). An exploration of the applicability of the refined disease risk index and its integration with other independent risk factors for individualized prognostication. Bone Marrow Transplantation. 52(3). 363–371. 3 indexed citations
12.
13.
Ma, Liyuan, Siguo Hao, Colin Phipps Diong, et al.. (2014). WPSS is a strong prognostic indicator for clinical outcome of allogeneic transplant for myelodysplastic syndrome in Southeast Asian patients. Annals of Hematology. 94(5). 761–769. 1 indexed citations
14.
15.
Hwang, William Ying Khee, Colin Phipps Diong, Kevin Tay, et al.. (2014). A Phase 2 Study of Panobinostat (PAN) in Combination with Bortezomib (BTZ) in Patients with Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL) or NK/T-Cell Lymphoma (NKL). Blood. 124(21). 503–503. 4 indexed citations
16.
Ong, Shin-Yeu, Aloysius Ho, Yeh Ching Linn, et al.. (2014). Use of Valacyclovir for the Treatment of Cytomegalovirus Antigenemia after Hematopoietic Stem Cell Transplantation. Blood. 124(21). 1098–1098.
17.
Wong, Yu Jun, M. Tao, Rina Hui, et al.. (2014). Role of Bone Marrow Evaluation (Bme) in Primary Central Nervous System Lymphoma (Pcnsl) in a Multiracial Asian Population. Annals of Oncology. 25. iv144–iv144. 1 indexed citations
18.
Diong, Colin Phipps, et al.. (2013). Methotrexate-induced myelopathy mimicking subacute combined degeneration of the spinal cord. Journal of Clinical Neuroscience. 20(7). 1025–1026. 17 indexed citations
19.
20.
Wong, Anni, Jeffrey C. Allen, Yeow Tee Goh, et al.. (2011). Single center retrospective analysis of BU-based conditioning regimens in allogeneic transplantation. Bone Marrow Transplantation. 47(2). 181–189. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nashla Barroso Breakdown of academic impact, for papers by Krishan Thirunavukkarasu Breakdown of academic impact, for papers by Dipenkumar Modi Breakdown of academic impact, for papers by Malini Bhole Breakdown of academic impact, for papers by Yvonne Sundström Breakdown of academic impact, for papers by Elizabeth Brém Breakdown of academic impact, for papers by Lena Marinova Breakdown of academic impact, for papers by Shin‐ichi Fuchida Breakdown of academic impact, for papers by Luis Aversa Breakdown of academic impact, for papers by Shin Young Hyun
Rankless by CCL
2026